Displaying 1 to 20 of 57 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Actimis Pharmaceuticals Inc Biopharmaceutical company focused on the development of small molecule therapeutics for respiratory and inflammatory disorders. |
United States | N/A Active |
||
|
Aderis Pharmaceuticals Inc Novel small molecule, receptor-specific therapeutics company for the treatment of central nervous system, cardiovascular and renal diseases. |
United States | 9 Oct 2001 | Series D Initial investment. Round participant. Active |
|
|
|
Aderis Pharmaceuticals Inc Novel small molecule, receptor-specific therapeutics company for the treatment of central nervous system, cardiovascular and renal diseases. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Advanced Cardiovascular Systems |
N/A Initial investment. Round participant. Active |
|||
|
|
Altor Bioscience Corp Biopharmaceutical company developing a new class of therapeutic products for the treatment of cancer, viral infections and autoimmune diseases. |
United States | N/A Active |
||
|
|
Artielle ImmunoTherapeutics Inc Developer of compound for the treatment of multiple sclerosis. |
United States | N/A Active |
||
|
|
Asteres Inc Commercialized a system to store and deliver finished prescriptions to consumers in retail pharmacy. |
United States | N/A |
||
|
|
AtheroGenics Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Axikin Pharmaceuticals Inc Biopharmaceuticals company focused on the development of novel therapeutics for respiratory disorders. |
United States | N/A Active |
||
|
|
BioSpace Inc Most comprehensive life sciences-related information resource company. |
United States | N/A |
||
|
|
CalciMedica Discoverer and developer of novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. |
United States | N/A |
||
|
|
Cardionet Inc |
United States | N/A |
||
|
|
Chimerix Inc |
United States | 1 Aug 2009 | Series E |
|
|
|
Chimerix Inc |
United States | 1 Nov 2004 | Series C |
|
|
|
Chimerix Inc |
United States | 1 Feb 2007 | Series D |
|
|
|
Chimerix Inc |
United States | 1 Feb 2011 | Series F |
|
|
|
Chimerix Inc |
United States | 1 Sep 2003 | N/A |
|
|
|
CoMentis Inc |
United States | N/A |
||
|
|
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. |
United States | 1 Jan 2007 | Series C Active |
|
|
|
Dendreon Corp A biotechnology company focused on targeting cancer |
United States | N/A |